313 related articles for article (PubMed ID: 29225033)
1. Mutant p53 Gains Its Function via c-Myc Activation upon CDK4 Phosphorylation at Serine 249 and Consequent PIN1 Binding.
Liao P; Zeng SX; Zhou X; Chen T; Zhou F; Cao B; Jung JH; Del Sal G; Luo S; Lu H
Mol Cell; 2017 Dec; 68(6):1134-1146.e6. PubMed ID: 29225033
[TBL] [Abstract][Full Text] [Related]
2. It takes a team: a gain-of-function story of p53-R249S.
Wang H; Liao P; Zeng SX; Lu H
J Mol Cell Biol; 2019 Apr; 11(4):277-283. PubMed ID: 30608603
[TBL] [Abstract][Full Text] [Related]
3. Co-targeting p53-R249S and CDK4 synergistically suppresses survival of hepatocellular carcinoma cells.
Wang H; Liao P; Zeng SX; Lu H
Cancer Biol Ther; 2020; 21(3):269-277. PubMed ID: 31747859
[TBL] [Abstract][Full Text] [Related]
4. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
[TBL] [Abstract][Full Text] [Related]
5. PIN1 in hepatocellular carcinoma is associated with TP53 gene status.
Bae JS; Noh SJ; Kim KM; Jang KY; Park HS; Chung MJ; Park BH; Moon WS
Oncol Rep; 2016 Oct; 36(4):2405-11. PubMed ID: 27499097
[TBL] [Abstract][Full Text] [Related]
6. Understanding the role of PIN1 in hepatocellular carcinoma.
Cheng CW; Leong KW; Tse E
World J Gastroenterol; 2016 Dec; 22(45):9921-9932. PubMed ID: 28018099
[TBL] [Abstract][Full Text] [Related]
7. Nicotine Promotes WRL68 Cells Proliferation Due to the Mutant p53 Gain-of-Function by Activating CDK6-p53-RS-PIN1-STAT1 Signaling Pathway.
Wang H; Chen L; Zhou T; Zhang Z; Zeng C
Chem Res Toxicol; 2020 Sep; 33(9):2361-2373. PubMed ID: 32820905
[TBL] [Abstract][Full Text] [Related]
8. Targeting Pin1 by inhibitor API-1 regulates microRNA biogenesis and suppresses hepatocellular carcinoma development.
Pu W; Li J; Zheng Y; Shen X; Fan X; Zhou JK; He J; Deng Y; Liu X; Wang C; Yang S; Chen Q; Liu L; Zhang G; Wei YQ; Peng Y
Hepatology; 2018 Aug; 68(2):547-560. PubMed ID: 29381806
[TBL] [Abstract][Full Text] [Related]
9. Pin1 impairs microRNA biogenesis by mediating conformation change of XPO5 in hepatocellular carcinoma.
Li J; Pu W; Sun HL; Zhou JK; Fan X; Zheng Y; He J; Liu X; Xia Z; Liu L; Wei YQ; Peng Y
Cell Death Differ; 2018 Sep; 25(9):1612-1624. PubMed ID: 29445125
[TBL] [Abstract][Full Text] [Related]
10. Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc.
D'Artista L; Bisso A; Piontini A; Doni M; Verrecchia A; Kress TR; Morelli MJ; Del Sal G; Amati B; Campaner S
Oncotarget; 2016 Apr; 7(16):21786-98. PubMed ID: 26943576
[TBL] [Abstract][Full Text] [Related]
11. Ser46 phosphorylation of p53 is an essential event in prolyl-isomerase Pin1-mediated p53-independent apoptosis in response to heat stress.
Li L; Su Z; Zou Z; Tan H; Cai D; Su L; Gu Z
Cell Death Dis; 2019 Feb; 10(2):96. PubMed ID: 30718466
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E.
Tu K; Zheng X; Zhou Z; Li C; Zhang J; Gao J; Yao Y; Liu Q
PLoS One; 2013; 8(7):e68574. PubMed ID: 23840897
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of CDK-mediated Smad3 phosphorylation reduces the Pin1-Smad3 interaction and aggressiveness of triple negative breast cancer cells.
Thomas AL; Lind H; Hong A; Dokic D; Oppat K; Rosenthal E; Guo A; Thomas A; Hamden R; Jeruss JS
Cell Cycle; 2017 Aug; 16(15):1453-1464. PubMed ID: 28678584
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma.
Zheng M; Xu H; Liao XH; Chen CP; Zhang AL; Lu W; Wang L; Yang D; Wang J; Liu H; Zhou XZ; Lu KP
Oncotarget; 2017 May; 8(18):29771-29784. PubMed ID: 28404959
[TBL] [Abstract][Full Text] [Related]
15. PIN1 Maintains Redox Balance via the c-Myc/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer Cells.
Liang C; Shi S; Liu M; Qin Y; Meng Q; Hua J; Ji S; Zhang Y; Yang J; Xu J; Ni Q; Li M; Yu X
Cancer Res; 2019 Jan; 79(1):133-145. PubMed ID: 30355620
[TBL] [Abstract][Full Text] [Related]
16. Generation of combined hepatocellular-cholangiocarcinoma through transdifferentiation and dedifferentiation in p53-knockout mice.
Liu Y; Xin B; Yamamoto M; Goto M; Ooshio T; Kamikokura Y; Tanaka H; Meng L; Okada Y; Mizukami Y; Nishikawa Y
Cancer Sci; 2021 Aug; 112(8):3111-3124. PubMed ID: 34051011
[TBL] [Abstract][Full Text] [Related]
17. The prolyl isomerase Pin1 interacts with and downregulates the activity of AMPK leading to induction of tumorigenicity of hepatocarcinoma cells.
Khanal P; Kim G; Yun HJ; Cho HG; Choi HS
Mol Carcinog; 2013 Oct; 52(10):813-23. PubMed ID: 22549912
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a Prenylated Flavonol Derivative as a Pin1 Inhibitor to Suppress Hepatocellular Carcinoma by Modulating MicroRNA Biogenesis.
Zheng Y; Pu W; Li J; Shen X; Zhou Q; Fan X; Yang SY; Yu Y; Chen Q; Wang C; Wu X; Peng Y
Chem Asian J; 2019 Jan; 14(1):130-134. PubMed ID: 30474357
[TBL] [Abstract][Full Text] [Related]
19. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults.
Zacchi P; Gostissa M; Uchida T; Salvagno C; Avolio F; Volinia S; Ronai Z; Blandino G; Schneider C; Del Sal G
Nature; 2002 Oct; 419(6909):853-7. PubMed ID: 12397362
[TBL] [Abstract][Full Text] [Related]
20. miR-874-3p is down-regulated in hepatocellular carcinoma and negatively regulates PIN1 expression.
Leong KW; Cheng CW; Wong CM; Ng IO; Kwong YL; Tse E
Oncotarget; 2017 Feb; 8(7):11343-11355. PubMed ID: 28076852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
